Search

everythinglearnresearchcommunity

for

Search:↓

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Dietary changes and supplements mostly did not improve alopecia areata.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

CD2 might be a new treatment target for patchy alopecia areata.

People with alopecia areata often have lower levels of zinc and vitamin D.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

The treatment using phenol and dexamethasone was effective for alopecia areata with no recurrence in 6 months.

A patient lost all their hair while on rheumatoid arthritis medication.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.